Literature DB >> 30488149

miR-34a in Neurophysiology and Neuropathology.

Christelle En Lin Chua1, Bor Luen Tang2,3.   

Abstract

Epigenetic influence of brain and neuronal function plays key regulatory roles in health and diseases. The microRNA miR-34a is a tumor suppressor transcript, and its loss has been prominently linked to various human cancers, including malignancies of the brain. Interestingly, miR-34a is abundantly expressed in the adult mammalian brain, and emerging evidence has implicated its involvement in a range of neurodevelopmental and neuropathological processes. Developmentally, miR-34a regulates neural stem/progenitor cell differentiation and aspects of neurogenesis. During aging, its elevation is connected to hearing loss and age-related macular degeneration. Pathologically, its elevations during epileptic seizures and ischemic stroke contribute to neuronal injury and death. Inhibition or suppression of miR-34a improved neuronal survival against a variety of neurotoxins implicated in Parkinson's disease. Its elevation may also play a role in neuronal demise in animal models of Alzheimer's disease, and suppression of its levels may be generally neuroprotective. The roles and activities of miR-34a in the brain are modulated by factors that control its expression (such as Tp53/73), as well as its downstream target genes (such as the sirtuins SIRT1 and SIRT6) and signaling pathways (such the Notch pathway). We discuss here the known and emerging roles of the miR-34a regulatory network in neurophysiology and neuropathology.

Entities:  

Keywords:  Alzheimer’s disease; Neuropathology; SIRT1; SIRT6; Tp53; miR-34a

Mesh:

Substances:

Year:  2018        PMID: 30488149     DOI: 10.1007/s12031-018-1231-y

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  15 in total

1.  miRNA-34a suppresses colon carcinoma proliferation and induces cell apoptosis by targeting SYT1.

Authors:  Haichao Lu; Liang Hao; Hongfan Yang; Jianshe Chen; Jinxin Liu
Journal:  Int J Clin Exp Pathol       Date:  2019-08-01

Review 2.  Non-Coding RNAs as Novel Regulators of Neuroinflammation in Alzheimer's Disease.

Authors:  Yuqing Liu; Xin Cheng; Hongli Li; Shan Hui; Zheyu Zhang; Yang Xiao; Weijun Peng
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

Review 3.  miRNA Involvement in Cerebral Ischemia-Reperfusion Injury.

Authors:  Maria-Adriana Neag; Andrei-Otto Mitre; Codrin-Constantin Burlacu; Andreea-Ioana Inceu; Carina Mihu; Carmen-Stanca Melincovici; Marius Bichescu; Anca-Dana Buzoianu
Journal:  Front Neurosci       Date:  2022-06-10       Impact factor: 5.152

4.  Dexmedetomidine Restores Autophagic Flux, Modulates Associated microRNAs and the Cholinergic Anti-inflammatory Pathway upon LPS-Treatment in Rats.

Authors:  Widuri Kho; Clarissa von Haefen; Nadine Paeschke; Fatme Nasser; Stefanie Endesfelder; Marco Sifringer; Adrián González-López; Nadine Lanzke; Claudia D Spies
Journal:  J Neuroimmune Pharmacol       Date:  2021-08-06       Impact factor: 4.147

5.  Identification of serum microRNAs as diagnostic biomarkers for schizophrenia.

Authors:  Kuanjun He; Chuang Guo; Meng Guo; Shuping Tong; Qiuli Zhang; Hongjun Sun; Lin He; Yongyong Shi
Journal:  Hereditas       Date:  2019-06-27       Impact factor: 3.271

Review 6.  Potential microRNA-related targets in clearance pathways of amyloid-β: novel therapeutic approach for the treatment of Alzheimer's disease.

Authors:  Soheil Madadi; Heidi Schwarzenbach; Massoud Saidijam; Reza Mahjub; Meysam Soleimani
Journal:  Cell Biosci       Date:  2019-11-12       Impact factor: 7.133

Review 7.  MicroRNAs at the Crossroad of the Dichotomic Pathway Cell Death vs. Stemness in Neural Somatic and Cancer Stem Cells: Implications and Therapeutic Strategies.

Authors:  Andrea Diana; Giuseppe Gaido; Cristina Maxia; Daniela Murtas
Journal:  Int J Mol Sci       Date:  2020-12-17       Impact factor: 5.923

8.  Plasma microRNA signature in presymptomatic and symptomatic subjects with C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Virgilio Kmetzsch; Vincent Anquetil; Dario Saracino; Daisy Rinaldi; Agnès Camuzat; Thomas Gareau; Ludmila Jornea; Sylvie Forlani; Philippe Couratier; David Wallon; Florence Pasquier; Noémie Robil; Pierre de la Grange; Ivan Moszer; Isabelle Le Ber; Olivier Colliot; Emmanuelle Becker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-11-25       Impact factor: 10.154

9.  MicroRNA‑34a‑5p expression in the plasma and in its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study.

Authors:  Ilaria Grossi; Annalisa Radeghieri; Lucia Paolini; Vanessa Porrini; Andrea Pilotto; Alessandro Padovani; Alessandra Marengoni; Alessandro Barbon; Arianna Bellucci; Marina Pizzi; Alessandro Salvi; Giuseppina De Petro
Journal:  Int J Mol Med       Date:  2020-12-02       Impact factor: 4.101

10.  Neurodevelopment regulators miR-137 and miR-34 family as biomarkers for early and adult onset schizophrenia.

Authors:  Bao-Yu Chen; Jin-Jia Lin; Ming-Kun Lu; Hung-Pin Tan; Fong-Lin Jang; Sheng-Hsiang Lin
Journal:  NPJ Schizophr       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.